Leslie Norwalk V.

Companies

• CVS HealthBoard member Nov 25, 2024 to now¹
• Globus MedicalBoard member Sep 6, 2023 to now²
• Neurocrine BiosciencesBoard member Sep 12, 2019 to now³
• Arvinas (United States)Board member Jul 26, 2019 to now⁴
• ModivCare IncBoard member Nov 5, 2015 to now⁵
• NuVasiveBoard member May 23, 2014 to Sep 5, 2023⁶
• Centene CorporationBoard member Jan 18, 2022 to Apr 4, 2022⁷
• Magellan HealthBoard member Apr 5, 2019 to Jan 4, 2022⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Globus Medical GMED10,419 shares⁹$791.0K at $75.92Jan 8, 2026
• CVS Health CVS7,376 shares¹⁰$681.4K at $92.39May 14, 2026
• Neurocrine Biosciences NBIX2,430 shares¹¹$333.8K at $137.36Jul 29, 2026
• AUArvinas (United States) ARVN41,572 shares¹²$298.7K at $7.18Jun 24, 2026
• Centene Corporation CNC1,481 shares¹³$102.5K at $69.19Mar 31, 2022
• Magellan Health MGLN0 shares¹⁴Jan 4, 2022
• NuVasive NUVA0 shares¹⁵Sep 1, 2023
• MModivCare Inc18,830 shares¹⁶Feb 14, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 29, 2026Exercised options 842 shares at $139.43 of Neurocrine Biosciences¹¹
• Jul 28, 2026Sold 1,250 shares at $182.01 of Neurocrine Biosciences¹¹
• Jun 24, 2026Granted 15,527 shares of Arvinas (United States)¹²
• Jun 4, 2026Sold 1,250 shares at $168.06 of Neurocrine Biosciences¹⁷
• May 21, 2026Exercised options 1,659 shares of Neurocrine Biosciences¹⁸
• May 14, 2026Granted 1,447 shares at $97.15 of CVS Health¹⁰
• May 12, 2026Sold 3,810 shares at $155.01 of Neurocrine Biosciences¹⁹
• Jan 8, 2026Sold 2,000 shares at $101.10 of Globus Medical⁹
• Dec 16, 2025Sold 1,190 shares at $155.09 of Neurocrine Biosciences²⁰
• Dec 15, 2025Sold 5,000 shares at $152.23 of Neurocrine Biosciences²⁰
• Dec 15, 2025Exercised options 1,724 shares at $84.95 of Neurocrine Biosciences²⁰
• Dec 15, 2025Exercised options 8,276 shares at $92.35 of Neurocrine Biosciences²⁰
• Dec 12, 2025Sold 4,000 shares at $88.85 of Globus Medical²¹
• Nov 20, 2025Granted 1,652 shares at $76.04 of CVS Health²²
• Jun 25, 2025Granted 16,025 shares of Arvinas (United States)²³
• May 22, 2025Exercised options 1,435 shares of Neurocrine Biosciences²⁴
• May 15, 2025Granted 2,077 shares at $60.47 of CVS Health²⁵
• Nov 21, 2024Granted 2,200 shares at $57.10 of CVS Health²⁶
• Jul 11, 2024Sold 1,000 shares at $70.00 of Globus Medical²⁷
• May 29, 2024Granted 5,899 shares of Arvinas (United States)²⁸
• May 17, 2024Sold 1,106 shares at $141.82 of Neurocrine Biosciences²⁹
• May 17, 2024Exercised options 2,100 shares of Neurocrine Biosciences²⁹
• Mar 15, 2024Sold 10,590 shares at $51.99 of Globus Medical³⁰
• Feb 27, 2024Sold 8,000 shares at $135.67 of Neurocrine Biosciences³¹
• Feb 27, 2024Exercised options 8,000 shares at $84.95 of Neurocrine Biosciences³¹